Skip to content

Capivasertib

Brand name: Truqap

Capivasertib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.

Capivasertib pill images

160 mg 2 pills

200 mg 2 pills

What is Capivasertib used for?

Capivasertib is used for breast cancer.

Official uses from the US prescribing label

HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

TRUQAP, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alteration as detected by an FDA-authorized test following progression on at least one endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy.

PTEN-Deficient Metastatic Androgen Pathway Modulation-Naïve or -Sensitive Prostate Cancer

TRUQAP, in combination with abiraterone and prednisone, is indicated for the treatment of adult patients with metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer that is PTEN-deficient as detected by an FDA-authorized test.

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.